Osamu Honmou

Osamu Honmou, MD, PhD, serves as an Adjunct Assistant Professor in the Department of Neurology at Yale University School of Medicine. His research program centers on translational applications of stem cell therapies for neurological disorders, with active collaborations across neurology, neurosurgery, and regenerative medicine disciplines.

Dr. Honmou completed both his medical degree (MD) in 1989 and doctoral studies (PhD) in 1999 at Sapporo Medical University in Japan, establishing foundational expertise in neurological research and clinical neurology.

His primary research focuses on mesenchymal stem cell mechanisms for neural repair, particularly investigating blood-spinal cord barrier restoration, modulation of oxidative stress, and combinatorial approaches with rehabilitation therapy. Current work emphasizes optimizing delivery protocols (including auto-serum expansion techniques) for chronic spinal cord injury, cerebral ischemia, and traumatic brain injury, with significant attention to functional recovery metrics in both preclinical and clinical settings.

Analysis of Dr. Honmou's 2023-2025 publications reveals a cohesive research trajectory centered on mesenchymal stem cell therapeutics. Key thematic clusters include intravenous delivery optimization (dose frequency, serum expansion), mechanistic studies of extracellular vesicles in barrier repair, and translational work bridging animal models to human case series. His research consistently addresses critical bottlenecks in regenerative neurology, particularly regarding chronic phase intervention and multimodal treatment approaches.

Dr. Honmou maintains a robust collaborative network with key researchers including Jeffery Kocsis (frequent co-author on 8 publications), Masanori Sasaki, and Karen Lankford, forming a specialized team focused on stem cell applications for neurological recovery. While specific grant details aren't provided in available materials, his publication pattern indicates sustained research funding supporting both laboratory investigations and clinical case series.

The research group operates within Yale's Neurology Department infrastructure, utilizing specialized facilities including the Clinical Neurosciences Imaging Center (CNIC) for neuroimaging components of stem cell studies. Current work shows progression toward human applications, particularly in chronic spinal cord and brain injury rehabilitation contexts.